ÇULHA, M. G. Et Al. 2016. Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy. MEDICAL HYPOTHESES , vol.94 , 151-153.

ÇULHA, M. G., İNKAYA, A. Ç., YİLDİRİM, E., ÜNAL, S., & ŞEREFOĞLU, E. C., (2016). Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy. MEDICAL HYPOTHESES , vol.94, 151-153.

ÇULHA, Mehmet Et Al. "Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy," MEDICAL HYPOTHESES , vol.94, 151-153, 2016

ÇULHA, Mehmet G. Et Al. "Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy." MEDICAL HYPOTHESES , vol.94, pp.151-153, 2016

ÇULHA, M. G. Et Al. (2016) . "Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy." MEDICAL HYPOTHESES , vol.94, pp.151-153.

@article{article, author={Mehmet Gokhan ÇULHA Et Al. }, title={Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy}, journal={MEDICAL HYPOTHESES}, year=2016, pages={151-153} }